A Novel Dipotassium Hydrogen Phosphate Phantom for Calibrating Computed Tomographic Bone Density Measurements in Birds.

The objective of this study was to construct a calibration phantom for bone mineral density (BMD) measurements adapted to avian anatomy by quantitative computed tomography. The determination of BMD is important to assess avian osteoporosis in poultry at production facilities and to study biological features in association with flight patterns in birds. Quantitative computed tomography measured in Hounsfield units is a well-established technique for BMD measurements. Translation of Hounsfield units into the International System of Units (mg/cm3) requires the use of a calibration phantom. Although calibration phantoms for routine use in humans are commercially available, phantoms suited to avian anatomy are not. A liquid dipotassium hydrogen phosphate calibration standard was constructed out of commercially available materials, easily allowing for variations in size, bone diameter, and adaptation to avian skeletal anatomy. Periodically, quantitative computed tomography scans were performed to monitor constant correlation to the calibration standard over 3 months and to monitor for the potential influence of gas bubbling and water evaporation in the rods on BMD measurements. Finally, the calibration phantom was tested for BMD measurements with carcasses from 2 bird species, including 3 peregrine falcons (Falco peregrinus; 2 juvenile males, 1 adult female with inactive reproductive status) and 4 Eurasian kestrels (Falco tinnunculus; 1 juvenile and 2 adult males, 1 adult female with inactive reproductive status). Results demonstrated stability of the calibration phantom without the need to refill or replace rods, plus a stable correlation line (R 2 = .99) over the 3-month evaluation period. It was possible to place the phantom directly on the bird carcasses, close to the measured bones, to improve BMD analysis. As evaluated, the phantom appeared to be adaptive to avian skeletal anatomy. Moreover, it was possible to build the phantom within 24 hours from commercially available materials.

Comparison of Two Treatment Modalities and PCR to Assess Treatment Effectiveness in Macrorhabdosis.

Macrorhabdosis is a debilitating disease condition that affects budgerigars (Melopsittacus undulatus), cockatiels (Nymphicus hollandicus), and many other bird species worldwide. Macrorhabdus ornithogaster is a pathogen which leads to nonspecific clinical signs, and to date, diagnosis as well as therapy are still challenging. In this study, medical histories of 32 budgerigars and 7 cockatiels with macrorhabdosis diagnosed clinically and by polymerase chain reaction (PCR) within a period of 24 months (from January 2016 to January 2018) were retrospectively analyzed. Macrorhabdus ornithogaster was diagnosed through fecal samples collected over several days and analyzed by microscopic examination or PCR. The effectiveness of 2 different amphotericin B treatment regimens were investigated by PCR. In 23 cases, treatment was performed with amphotericin B via drinking water at 0.1 mg/mL for 28 days. For the remaining 16 birds, an alternative treatment regimen of amphotericin B at 100 mg/kg PO q12h for 10 days was combined with administration of amphotericin B via drinking water at 0.1 mg/mL for 28 days. Fecal samples of all treated flocks were reexamined by PCR 10-14 days post-amphotericin B treatment. More than half (56.4%) of the treated birds tested negative for M ornithogaster irrespective of the treatment regimen. In addition to clinical improvement and microscopic examination of droppings, PCR was used for the first time to evaluate treatment response in birds diagnosed with M ornithogaster. Administration of amphotericin B via drinking water proved to be effective in more than 50% of cases, indicating a less stressful alternative to the oral administration of amphotericin B twice daily.